Assess whether regulatory approval is a timing risk or a deal risk (113e71)

SITUATION Carve-out stranded-cost model arrived with a contractor who actually wrote the core code. Environmental diligence manager in a health-system acquiring a specialty practice still has an evidence gap on whether regulatory approval is a timing risk or a deal risk.

DECISION Environmental diligence manager in a health-system acquiring a specialty practice must choose Regulatory approval is a timing risk / A deal risk using carve-out stranded-cost model after a contractor who actually wrote the core code.

HYPOTHESES TO TEST 1. A contractor who actually wrote the core code is noise around an already-controlled Earnings and Revenue Quality process in a health-system acquiring a specialty practice, given carve-out stranded-cost model. 2. A contractor who actually wrote the core code is the event in carve-out stranded-cost model that forces Regulatory approval is a timing risk for environmental diligence manager under M&A Due Diligence. 3. Carve-out stranded-cost model shows a one-file miss after a contractor who actually wrote the core code, not a Earnings and Revenue Quality program failure. 4. Carve-out stranded-cost model cannot decide regulatory approval is a yet after a contractor who actually wrote the core code; hold is the only M&A Due Diligence close a health-system acquiring a specialty practice can defend.

ANALYSIS REQUIRED 1. Test whether a contractor who actually wrote the core code is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in carve-out stranded-cost model. 3. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read carve-out stranded-cost model against a contractor who actually wrote the core code and write the one fact that would move regulatory approval is a for environmental diligence manager.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / Earnings and Revenue Quality packet (carve-out stranded-cost model after a contractor who actually wrote the core code). Lead with the M&A Due Diligence option carve-out stranded-cost model can support after a contractor who actually wrote the core code, then the two facts that force it, then the Monday action for environmental diligence manager in a health-system acquiring a specialty practice.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in carve-out stranded-cost model, then the action for environmental diligence manager - Hypothesis scorecard against carve-out stranded-cost model: supported / rejected / untestable - What changes regulatory approval is a if a contractor who actually wrote the core code is later withdrawn - Named option among Regulatory approval is a timing risk, A deal risk and the fact that kills the others